Indication

Neulasta® is a prescription medication used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid), who receive anti-cancer medicines (chemotherapy) that can cause fever and low blood cell count.

Neulasta® is a prescription medication used to help reduce the chance of infection due to a low white blood cell count, in people with certain types of cancer (non-myeloid), who receive anti-cancer Read more medicines (chemotherapy) that can cause fever and low blood cell count. Close

Neulasta® is a prescription medication used to help reduce the chance of infection due to a low white blood cell count, Read more in people with certain types of cancer (non-myeloid), who receive anti-cancer medicines (chemotherapy) that can cause fever and low blood cell count. Close

You are now leaving Neulasta.com

The sponsors of this site are not responsible for content on the site you are about to enter.

You are going to a website that contains clinical information and was created specifically for healthcare professionals. If you are not a healthcare professional, and would like to return to the consumer site, please click CANCEL.

Help Paying for Neulasta®

There are programs available that may help you pay for Neulasta®:

Neulasta FIRST STEP®
Co-Pay Coupon Program

Neulasta FIRST STEP® Co-Pay Coupon Program helps limit your Neulasta® out-of-pocket cost based on eligibility

The Neulasta FIRST STEP® Program is a Co-Pay Coupon program that can help commercially insured patients meet their Neulasta® deductible, co-insurance, and/or co-payment (out-of-pocket) requirement.

Neulasta FIRST STEP Program

89% of Neulasta® patients had $0 out-of-pocket costs, based on a national claims database*

* National claims database included 166,581 patients, across all insurance types, between January 2011 and August 2014. Estimated amount of Medicare beneficiaries with supplemental coverage and commercially insured patients with no out-of-pocket cost, based on Oncology Clinic data provided by IMS looking at 835 Remittance Advise and pre-adjudicated 837 Claim Forms in a Report dated August 1, 2014. Does not include costs related to office visit, physician, staff, or administrative charges associated with administering Neulasta®.

Log on to www.AmgenFIRSTSTEP.com or call 1-888-657-8371 for more information.


Amgen Assist®

In addition to the programs that Amgen sponsors, Amgen makes donations to independent nonprofit co-pay patient assistance foundations that in turn give grants to assist qualifying insured patients who need help with out-of-pocket costs for medicines manufactured from across all of the industry. Such foundations make patient grant decisions based upon their own criteria, and Amgen has no influence over such decisions. Patients who are insured (through private or government programs) but need financial assistance can be referred to these independent foundations for help.

Patients with commercial or government insurance (including Medicare) who need additional financial assistance can contact independent co-payment foundations, or Amgen Assist can refer patients to independent nonprofit co-payment foundations. Since these co-payment foundations are independent and not affiliated with Amgen, Amgen Assist® cannot guarantee that a patient will receive assistance. Each foundation has its own eligibility criteria, which include an evaluation of each individual's financial, medical, and insurance status.

For more information about co-pay support, or to get contact information for independent co-pay foundations, or for a referral to an independent co-pay foundation, contact an Amgen Assist® service specialist at 1-888-4ASSIST (1-888-427-7478).

Consider the possibility of fewer doctor visits with Neulasta® Onpro™*

* If, for any reason, you believe you did not receive your full dose of Neulasta® or that your On-body Injector is not working correctly, immediately contact your healthcare provider

Learn more

Important Safety Information

Who should not take Neulasta®?

Do not take Neulasta® if you have had a serious allergic reaction to Neulasta® (pegfilgrastim) or to NEUPOGEN® (filgrastim).

What should I tell my health care provider before taking Neulasta®? Tell your healthcare provider if you:

  • Have sickle cell trait or sickle cell disease
  • Have had severe skin reactions to acrylic adhesives
  • Are allergic to latex
  • Have problems with your kidneys
  • Have any other medical problems
  • Are pregnant or plan to become pregnant. It is not known if Neulasta® may harm your unborn baby.
  • Are breastfeeding or plan to breastfeed. It is not known if Neulasta® passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are possible serious side effects of Neulasta®?

  • Spleen Rupture. Your spleen may become enlarged and can rupture while taking Neulasta®. A ruptured spleen can cause death. Call your doctor right away if you have pain in the left upper stomach area or left shoulder tip area. This pain could mean your spleen is enlarged or ruptured.
  • A serious lung problem called Acute Respiratory Distress Syndrome (ARDS). Call your healthcare provider or get emergency medical help right away if you get any of these symptoms of ARDS: fever, shortness of breath, trouble breathing, or a fast rate of breathing.
  • Serious Allergic Reactions. Get emergency medical help right away if you get any of these symptoms of a serious allergic reaction with Neulasta®: shortness of breath, wheezing, dizziness, swelling around the mouth or eyes, fast pulse, sweating, and hives.

If you have an allergic reaction during the delivery of Neulasta®, remove the On-body Injector for Neulasta® by grabbing the edge of the adhesive pad and peeling off the On-body Injector. Get emergency medical help right away.

  • Sickle Cell Crises. Severe sickle cell crises, and sometimes death, can happen in people with sickle cell trait or disease who receive filgrastim, a medicine similar to Neulasta®.
  • Kidney injury (glomerulonephritis). Kidney injury has been seen in patients who received Neulasta®. You should notify your healthcare provider right away if you experience puffiness in your face or ankles, blood in your urine or brown colored urine or you notice you urinate less than usual.
  • Increased white blood cell count (leukocytosis). Your doctor will check your blood during treatment with Neulasta®.
  • Capillary Leak Syndrome. Neulasta® can cause fluid to leak from blood vessels into your body’s tissues. This condition is called "Capillary Leak Syndrome" (CLS). CLS can quickly cause you to have symptoms that may become life-threatening. Get emergency medical help right away if you develop any of the following symptoms:
    • swelling or puffiness and are urinating less often
    • trouble breathing
    • swelling of your stomach area (abdomen) and feeling of fullness
    • dizziness or feeling faint
    • a general feeling of tiredness

The most common side effect of Neulasta® is pain in the bones and in your arms and legs.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of Neulasta®. Call your doctor for medical advice about side effects. You may report negative side effects to the FDA at 1-800-FDA-1088.

For more information about Neulasta®, talk with your healthcare provider or pharmacist; go to www.neulasta.com, or call 1-844-696-3852 (1-844-MYNEULASTA).

Please see Neulasta® Patient Information.

Important Safety Information
Who should not take Neulasta®?
Do not take Neulasta® if you have had a serious allergic reaction to Neulasta® (pegfilgrastim) or to NEUPOGEN® (filgrastim).
What should I tell my health care provider before taking Neulasta®? Tell your healthcare provider if you:
• Have sickle cell trait or sickle cell disease

See More Close